Mikoflyukan: ntuziaka maka ojiji

onunu ogwu ụdị

Nkwadebe "Mikoflyukan" ntụziaka maka nke a na-egosi n'okpuru ike-emepụta n'ụdị mbadamba na dị iche iche kasịnụ nke nọ n'ọrụ umi ma ọ bụ n'ụdị ihe ngwọta maka infusion. The mbadamba na-acha ọcha, gburugburu udi na ubé bevelled n'ọnụ ya.

Na mbadamba nwere 50 mg nke nọ n'ọrụ umi na ma akụkụ nke echiche «F», na ndị ọzọ - "50". The mbadamba ụdị "Mikoflyukan" 150 mg nke nọ n'ọrụ mgwa - «F150» na n'ikewa akara, karị.

The ngwọta nkwadebe bụ colorless, uzo, na-enweghị ihe ọ bụla ahụ.

Mejupụtara: Mbadamba

Active umi: fluconazole - 50/150 mg (1 tab.).

Excipients:

- sịlịkọn dioxide ,

- lactose,

- povidone,

- magnesium stearate

- Valium,

- talc,

- cellulose mikrokristallicheskayae

ngwọta

Active umi: fluconazole - 2/200 mg (1 ml mkpọ na 1, karị).

Excipients:

- Mmiri maka ịgba ntụtụ,

- sodium chloride.

The pharmacological edinam nke ọgwụ "Mikoflyukan"

Guide na-ekwu na nkwadebe akọ antifungal mmadụ nke triazole emepụta. Fluconazole inhibit ergosterol njikọ dị ka ndị a: ọ na-enye ndị permeability nke na cell mgbidi. The ọgwụ na-arụ ọrụ megide Microsporum, Candida, Trichophyton, Cryptococcus neoformans.

A atụmatụ nke pharmacological edinam nke ọgwụ bụ na ọ bụ ma nhọrọ inhibitor nke cytochrome P450 na fungi, ma n'otu oge, adịghị egosi na ihe ọ bụla ọrụ megide a enzyme usoro mmadụ.

Pharmacokinetics

The ọgwụ na-ọma-etinye obi gị dum mgbe ochichi, na nri oriri na njikọ na-ewere ọgwụ adịghị emetụta ya absorption. Bioavailability - 90%. The ọgwụ na-ekesa nile akụkụ na anụ ahụ nke ahụ. N'ihi ya ya ịta na plasma ịta hà na-esonụ akụkụ na anụ ahụ: nkwonkwo ọmụmụ, mmiri ara, asu, mmamiri secretions, sputum na perinatal ọmụmụ, na cerebrospinal ọmụmụ bioavailability nwere ike mbio 50 90%.

Ọzọkwa, ụfọdụ akụkụ na anụ ahụ nke ọgwụ ịta ike gafere ịta na plasma. N'etiti ha, ndị epidermis, na dermis, na stratum corneum, ọsụsọ mmiri mmiri. The ọkara ndụ - banyere 30 awa.

Egosi maka ojiji nke ọgwụ "Mikoflyukan"

Iwu ahụ kwuru na ọgwụ nwere nnukwu ọrụ megide microorganisms ndị na-esonụ ọrịa, nke na-ewekarị fungal-efe efe:

• systemic candidiasis,

• cryptococcosis,

• mucosal candidiasis,

• mmamiri candidiasis,

• mgbochi nke fungal-efe efe

• akpụkpọ mycoses,

• onychomycosis,

• pityriasis versicolor,

• parakoktsidiovikoz,

• coccidioidomycosis,

• pistoplazmyuoz,

• sporotrichosis.

Mmetụta nke ọgwụ "Mikoflyukan"

Nyocha nke ule otu mgbe a na usoro nke ọmụmụ nke ọgwụ, gụnyere placebo-ule na ụzọ ndị ọzọ nke nnyocha gosiri na ọgwụ ike ndị na-esonụ mmetụta:

- na ùgwù nke digestive tract:

• abdominal mgbu,

• ọgbụgbọ,

• flatulence,

• afọ ọsịsa;

- na ùgwù nke Central ụjọ usoro akụkụ:

• dizziness,

• isi ọwụwa;

- banyere nfụkasị Jeremaya:

• anaphylactic Jeremaya mere nke organism,

• akpụkpọ ọkụ ọkụ.

Contraindications ọgwụ "Mikoflyukan"

Ntuziaka ka ọgwụ na-ekwu na ndị contraindications ya n'ikuku bụ obere ezu, n'etiti ha:

• ruo 1 afọ,

• afọ ime,

• uche na triazole compound na fluconazole.

ọgwụ interactions

Prothrombin oge na-abawanye mgbe ojiji nke ọgwụ ọjọọ anticoagulant coumarin ụdị.

Nkwekọrịta nke sulfonylurea onu hypoglycemic mmadụ budata dịkwuo ha ọkara ndụ na kọntaktị na fluconazole.

Fluconazole ọkara ndụ oge na-ebelata mgbe kpọtụụrụ na rifampicin.